News Breaks |
|
|
| October 22, 2012 |
| 06:43 EDT |  | VOLC, STJ | Volcano legal win a best-case scenario, says Leerink
Leerink believes Volcano's (VOLC) legal win Friday against St. Jude Medical (STJ) presents a best-case scenario and removes a headline risk for the company. The firm reiterates an Outperform rating on shares of Volcano with a $32 price target. |
|
|
News For VOLC;STJ From The Last 14 Days Check below for free stories on VOLC;STJ the last two weeks. |
|
|
| May 23, 2013 |
| 05:48 EDT |  | VOLC | Volcano announces preliminary results from ADVISE II study
 Subscribe for More Information |
|
| 05:44 EDT | | STJ | St. Jude Medical study of EnligHTN shows sustained blood pressure reduction
St. Jude Medical announced that the company's EnligHTN Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. Patients enrolled in the EnligHTN I trial had an average blood pressure of 176 / 96 mmHg and patients were drug-resistant, meaning their blood pressure could not be controlled through medication. At one year, patients treated with the EnligHTN Renal Denervation System experienced an average systolic blood pressure reduction of 27 mmHg points when measured in an office setting. |
|
| May 22, 2013 |
| 10:00 EDT |  | VOLC | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 06:31 EDT | | VOLC | Volcano upgraded to Overweight from Equal Weight at First Analysis
Subscribe for More Information |
|
| May 20, 2013 |
| 15:55 EDT | | VOLC | Volcano added to Best Ideas List at Barrington
Subscribe for More Information |
|
| 11:12 EDT | | STJ | St. Jude Medical to evaluate defibrilator lead related to reported death
Subscribe for More Information |
|
| May 16, 2013 |
| 08:05 EDT | | STJ | St. Jude Medical's 3-D vessel reconstruction system approved in Europe
St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. |
|
| May 14, 2013 |
| 08:09 EDT | | STJ | St. Jude Medical announces first patient enrolled in EnligHTN III study
Subscribe for More Information |
|
|
|
|
|
